Patent Application
Utility
PCT National Stage
App. No. 09/743,847
· Confirmation No. 9077
UNCOUPLING PROTEIN 4 (UCP-4)
Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
View Patent ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2001-06-27 | LET. |
Miscellaneous Incoming Letter | 76 | View |
Inventors
Attorneys & Agents of Record
Classification
USPC
530/350
C07K14/47
A61K48/00
Prosecution
- Examiner
- LI, RUIXIANG
- Art Unit
- 1674
- Customer No.
- 44638
- Docket No.
- 030639.0026.UTL
- Confirmation No.
- 9077
Patent Term Adjustment
0days
AMYLIN PHARMACEUTICALS, LLC ASSIGNS AN EQUAL AND UNDIVIDED ONE-HALF OF ITS ENTIRE RIGHT, TITLE AND INTEREST TO ASTRAZENECA PHARMACEUTICALS LP
Recorded 2012-10-26
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2002-01-29
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 09/743,847
- Filed
- 2001-06-27
- Granted
- 2003-08-05
- Examiner
- LI, RUIXIANG
- Art Unit
- 1674
- PTA
- 0 days
External Links